A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis

BACKGROUND: Many countries will not reach elimination targets for lymphatic filariasis in 2020 using the two-drug treatment regimen (diethylcarbamazine citrate [DEC] and albendazole [DA]). A cluster-randomized, community-based safety study performed in Fiji, Haiti, India, Indonesia and Papua New Gui...

Descripción completa

Detalles Bibliográficos
Autores principales: Krentel, Alison, Basker, Nandha, Beau de Rochars, Madsen, Bogus, Joshua, Dilliott, Daniel, Direny, Abdel N., Dubray, Christine, Fischer, Peter U., Ga, Adriani Lomi, Goss, Charles W., Hardy, Myra, Howard, Cade, Jambulingam, Purushothaman, King, Christopher L., Laman, Moses, Lemoine, Jean Frantz, Mallya, Shruti, Robinson, Leanne J., Samuela, Josaia, Schechtman, Ken B., Steer, Andrew C., Supali, Taniawati, Tavul, Livingstone, Weil, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928496/
https://www.ncbi.nlm.nih.gov/pubmed/33657090
http://dx.doi.org/10.1371/journal.pntd.0009002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928496/
https://www.ncbi.nlm.nih.gov/pubmed/33657090
http://dx.doi.org/10.1371/journal.pntd.0009002

Ejemplares similares